VIPoma: Understanding the Rare Pancreatic Neuroendocrine Tumor
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
TL;DR: A VIPoma is an exceptionally rare pancreatic neuroendocrine tumor that overproduces the vasoactive intestinal peptide (VIP) hormone. This hormonal surge leads to chronic, severe watery diarrhea, often referred to as Verner-Morrison syndrome. While the condition is rare—affecting roughly 1 in 10 million people [1]—it can lead to serious complications like dehydration and electrolyte imbalances. Fortunately, modern treatments including specialized medications and surgery offer effective management and, in some cases, a cure.
Quick Answer
A VIPoma is a rare tumor of the pancreas's endocrine cells that secretes excessive amounts of the hormone VIP, causing severe watery diarrhea that persists even during fasting. [1] It is diagnosed with hormone blood tests and CT or MRI scans. Treatment involves IV fluids and medications like octreotide, followed by surgical removal when possible, which may be curative.
What the research says
Surgery controls symptoms of localized VIPoma, but it is rarely curative. In a French multicenter series of 22 patients, most pancreatic neuroendocrine tumors were metastatic (77%); surgical excision of nonmetastatic VIPoma effectively controlled the secretory syndrome, yet 4 of 5 of those patients had metastatic recurrences (all were alive after a median 171 months of follow-up), and 5-year overall survival was 63.6% (According to PubMed, Brugel et al., Pancreatology, 2021) [2].
VIPomas can be aggressive and hard to control long term. In a very small single-center review of 293 patients with pancreatic neuroendocrine tumors, only 4 (1.4%) had VIPomas; all were in the pancreatic tail, hormonal symptoms recurred in all four despite initial control, and median survival was 5.9 years versus 26.7 years for non-functioning tumors (P < 0.0001) (According to PubMed, Murakami et al., Endocr J, 2022) [3].
A high VIP blood level alone does not confirm a VIPoma. In a single-institution study of 76 patients whose VIP exceeded the 75 pg/mL reference limit, only 9 had a VIPoma; the positive predictive value at that threshold was 12%, and the optimal threshold was 442 pg/mL (OR 11.96, 95% CI 2.00–79.69) (According to PubMed, Korleski et al., Endocr Relat Cancer, 2026) [4].
What is a VIPoma?
A VIPoma is a rare type of pancreatic neuroendocrine tumor (NET) that originates in the endocrine cells of the pancreas. [1] Its name is derived from the fact that it secretes vasoactive intestinal peptide (VIP), a hormone that plays a crucial role in regulating the digestive system. When a tumor produces unusually large amounts of this hormone, it disrupts the body's ability to manage water and salts, leading to chronic health issues. Healthcare providers sometimes refer to this clinical presentation as Verner-Morrison syndrome [1].
These tumors are remarkably rare, with experts estimating that they occur in only about 1 in 10 million people in the United States. [1] While they can be malignant (cancerous) [1], early detection and a comprehensive treatment plan can significantly improve the outlook for affected individuals.
Feature | VIPoma (Verner-Morrison Syndrome) |
Origin | Endocrine cells of the pancreas |
Primary Driver | Overproduction of VIP hormone |
Prevalence | ~1 in 10 million people |
Primary Symptom | Severe, chronic watery diarrhea |
Potential Outcome | May be cured with surgery in some cases |
Symptoms and Physical Signs
The hallmark of a VIPoma is severe, watery diarrhea that does not improve with dietary changes or fasting. [1] This symptom is often so intense that it significantly disrupts daily life and can lead to rapid fluid loss.
Common Clinical Symptoms
Watery Diarrhea: Severe episodes that persist even when not eating.
Abdominal Cramps: Persistent belly pain and discomfort.
Fatigue: A general sense of exhaustion due to nutrient and fluid loss.
Flushing: Sudden redness in the face and chest without an obvious cause.
Muscle Weakness: Often resulting from electrolyte imbalances caused by the tumor.
The Role of the VIP Hormone
In a healthy body, the vasoactive intestinal peptide (VIP) hormone supports normal digestion by managing the release of water, salts, enzymes, and gastric acid. [1] It also helps relax specific muscles within the digestive tract to facilitate the movement of food. [1] However, in the presence of a VIPoma, the flood of this hormone triggers the intestines to release massive amounts of water and salts, leading to the characteristic watery diarrhea associated with the condition.
Potential Complications
If left untreated, the chronic fluid loss from a VIPoma can lead to life-threatening complications. Some individuals may produce between 1 and 3 quarts of watery stool daily [1], resulting in:
Dehydration: Severe loss of body fluids.
Hypokalemia: Critically low levels of potassium in the blood.
Arrhythmia: Irregular heartbeats caused by electrolyte imbalances.
Hypovolemic Shock: A condition where severe fluid loss makes it difficult for the heart to pump enough blood.
Diagnosis and Diagnostic Testing
Because VIPoma is so rare, healthcare providers often perform a series of tests to rule out more common causes of chronic diarrhea. [1] The diagnostic process typically involves a combination of clinical assessment and advanced laboratory work.
Physical Examination: A thorough review of symptoms and medical history.
Stool Tests: Used to ensure the diarrhea isn't caused by common infections or other digestive diseases.
Blood Chemistry: Specifically measuring the levels of the VIP hormone in the bloodstream.
Imaging Technology: Computed tomography (CT) or magnetic resonance imaging (MRI) scans are used to locate the tumor within the pancreas and determine if it has spread.
Management and Treatment Pathways
The management of a VIPoma focuses on two main goals: stabilizing the patient by controlling symptoms and removing the underlying tumor.
Symptom Management
Initial treatment often involves IV fluids to replace the essential minerals and liquids lost through diarrhea. [1] Medications such as octreotide are frequently prescribed to help control the diarrhea by inhibiting the release of the VIP hormone.
Tumor Removal and Additional Therapies
Once the patient is stable, the focus shifts to treating the tumor:
Surgery: A distal pancreatectomy, which removes the body and tail of the pancreas, is an option if the tumor is localized. [1]
Additional Therapies: In cases where surgery isn't immediately possible or the tumor has spread, chemotherapy or targeted therapy may be recommended.
Outlook and Recovery
The outlook for VIPoma is best when the tumor is caught early and can be surgically removed. Surgery may cure VIPoma in some cases [1], while medication can reduce symptoms for those who are not candidates for immediate surgery. Every case is unique, and ongoing communication with a specialized healthcare team is essential for long-term health and symptom monitoring.
Conclusion
A VIPoma is a challenging and rare condition, but modern medicine provides clear pathways for diagnosis and treatment. By understanding the role of the VIP hormone and the importance of early intervention, patients can work with their healthcare teams to manage symptoms and pursue surgery when it is possible. If you or a loved one are experiencing persistent, unexplained digestive issues, seeking a professional evaluation is the first step toward recovery and a return to normal life.
Related reading: Neuroendocrine tumors · Pancreatectomy
Frequently Asked Questions
What is the most common sign of a VIPoma?
The most significant sign is severe, watery diarrhea that happens even when you are fasting and does not go away after several days.
Is a VIPoma always cancerous?
While a VIPoma can be malignant (cancerous), it is classified as a neuroendocrine tumor, and its behavior can vary. Some are slow-growing, while others may spread.
Can VIPoma be cured?
Surgery may cure VIPoma in some people, particularly when the tumor has not spread to other organs. Research suggests that surgery for localized VIPoma controls symptoms effectively but is not always curative, so long-term follow-up is important.
How much fluid can be lost due to this tumor?
Some people with VIPoma may produce between 1 and 3 quarts of watery stool every day, which can lead to rapid dehydration.
What is Verner-Morrison syndrome?
Verner-Morrison syndrome is another name for the collection of symptoms caused by a VIPoma, specifically the combination of watery diarrhea, low potassium, and low stomach acid.
How is the tumor located?
Doctors typically use imaging tests like CT scans or MRIs to find the exact location of the tumor in the pancreas.
What does the VIP hormone normally do?
VIP normally helps regulate digestion by managing the release of salts, water, and enzymes, and by relaxing muscles in the digestive tract.
Why does VIPoma cause muscle weakness?
The chronic diarrhea causes the body to lose essential electrolytes like potassium. Low potassium levels (hypokalemia) directly lead to muscle weakness and fatigue.
When should I see a doctor for chronic diarrhea?
You should seek medical attention if you have watery diarrhea that lasts for several days, severe belly pain, or symptoms of dehydration like feeling lightheaded.
Are there medications to stop the diarrhea?
Yes, medications like octreotide can help control the diarrhea by blocking the release of the hormone that triggers it.
References
Cleveland Clinic. VIPoma (Vasoactive Intestinal Peptide Secreting) Tumor. Cleveland Clinic. Last updated 12/03/2024. https://my.clevelandclinic.org/health/diseases/vipoma
Brugel M, Walter T, Goichot B, et al. Efficacy of treatments for VIPoma: a GTE multicentric series. Pancreatology. 2021;21(8):1531-1539. PMID 34404601. https://doi.org/10.1016/j.pan.2021.08.001
Murakami M, Fujimori N, Matsumoto K, et al. A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience. Endocr J. 2022;69(10):1201-1209. PMID 35644576. https://doi.org/10.1507/endocrj.EJ22-0111
Korleski J, Ospina Velasquez LE, Bornhorst J, et al. Elevated vasoactive intestinal peptide concentrations poorly predict VIPoma. Endocr Relat Cancer. 2026;33(1):e250241. PMID 41498509. https://doi.org/10.1530/ERC-25-0241
Medical disclaimer
This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions about a medical condition.
Comments